FDA Approves Onswik: A Once-Weekly Insulin For Adults With Type 2 Diabetes
If you live with type 2 diabetes (T2D) and find the frequency of multiple daily injections (MDI) dauntinghere’s a bit of good news: Eli Lilly announced the Food and Drug…
If you live with type 2 diabetes (T2D) and find the frequency of multiple daily injections (MDI) dauntinghere’s a bit of good news: Eli Lilly announced the Food and Drug…
The US Food and Drug Administration (FDA) has approved Eli Lilly and Company’s Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin injection for adults with type 2 diabetes (T2D). This…
September 24, 2026 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email…
Health 8 sources·Updated Sep 24, 2026 The U.S. Food and Drug Administration on Thursday, Sept. 24, 2026, approved Eli Lilly’s Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin for adults…
FDA approved of Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin indicated along with diet and exercise to control high blood sugar in adults with type 2 diabetes. With FDA’s…
September 17, 2026 1 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email…
The US Food and Drug Administration (FDA) has approved an updated label for insulin human (Afrezza) inhalation powder, which provides guidance for starting dosages when switching from multiple daily injections…
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden…
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. Glucagon-like peptide-1 (GLP-1) receptor agonists are designed to…
Underlying technology A brief history of CGM CGM is a wearable technology that allows users to track their blood sugar levels in real time. Historically, people with type 1 or…